Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...

Sen. Elizabeth Warren urges FTC to scrutinize Novo Nordisk's $16.5 billion acquisition of Catalent over concerns of increased ...

Based on these metrics and many more, TAK holds a Value grade of A, while CTLT has a Value grade of C. Both TAK and CTLT are impressive stocks with solid earnings outlooks, but based on these ...

On Monday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.61 which represents a slight increase of $0.02 or 0.03% from the prior close of $60.59. The stock opened at $60.53 and ...

U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk ...

Catalent Inc (CTLT) stock saw a decline, ending the day at $60.59 which represents a decrease of $-0.12 or -0.20% from the prior close of $60.71. The stock opened at $60.75 and touched a low of $60.5 ...

Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Takeda Pharmaceutical Co. (TAK) and Catalent (CTLT). But which of these two stocks is more attractive ...